Compounds > trilostane
Page last updated: 2024-08-22

trilostane and Adrenal Cortex Cancer

trilostane has been researched along with Adrenal Cortex Cancer in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Begon, D; Benchekroun, G; de Fornel-Thibaud, P; Delisle, F; Gomez, E; Héripret, D; Lafarge, S; Maurey, C; Moraillon, R; Rosenberg, D1
Eastwood, JM; Elwood, CM; Hurley, KJ1
Ito, S; Satoh, F1
Iitaka, M; Inaba, M; Katayama, S; Morita, T; Sasano, H; Yamanaka, K1
Komanicky, P; Melby, JC; Spark, RF1
Katayama, T; Koike, H; Nakada, T1

Reviews

1 review(s) available for trilostane and Adrenal Cortex Cancer

ArticleYear
[Adrenocortical adenoma].
    Nihon rinsho. Japanese journal of clinical medicine, 2006, May-28, Volume: Suppl 1

    Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Androgens; Biomarkers; Calcium Channel Blockers; Diagnostic Imaging; Dihydrotestosterone; Enzyme Inhibitors; Humans; Hydrocortisone; Metyrapone; Spironolactone

2006

Other Studies

5 other study(ies) available for trilostane and Adrenal Cortex Cancer

ArticleYear
Trilostane therapy for hyperadrenocorticism in three dogs with adrenocortical metastasis.
    The Veterinary record, 2008, Aug-09, Volume: 163, Issue:6

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Hyperfunction; Animals; Dihydrotestosterone; Dogs; Lung Neoplasms; Retrospective Studies

2008
Trilostane treatment of a dog with functional adrenocortical neoplasia.
    The Journal of small animal practice, 2003, Volume: 44, Issue:3

    Topics: 3-Hydroxysteroid Dehydrogenases; Adrenal Cortex Neoplasms; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Animals; Antineoplastic Agents; Blood Chemical Analysis; Dihydrotestosterone; Dog Diseases; Dogs; Female; Radiography; Ultrasonography

2003
A case of renin-producing adrenocortical cancer.
    Endocrine journal, 2000, Volume: 47, Issue:2

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; 3-Hydroxysteroid Dehydrogenases; Adrenal Cortex Neoplasms; Biopsy, Needle; Catecholamines; Cytochrome P-450 Enzyme System; Dihydrotestosterone; Enzyme Inhibitors; Female; Glucocorticoids; Gonadal Steroid Hormones; Humans; Hydrocortisone; Hypertension; Hypokalemia; Middle Aged; Mitotane; Muscle Weakness; Neoplasm Metastasis; Renin; Thirst; Tomography, X-Ray Computed

2000
Treatment of Cushing's syndrome with trilostane (WIN 24,540), an inhibitor of adrenal steroid biosynthesis.
    The Journal of clinical endocrinology and metabolism, 1978, Volume: 47, Issue:5

    Topics: 17-Ketosteroids; Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Adult; Blood Pressure; Carcinoma; Cushing Syndrome; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Female; Humans; Hydrocortisone; Kinetics; Male; Middle Aged; Mineralocorticoids; Potassium; Renin

1978
Uneventful delivery following series of successive treatments for virilized Cushing syndrome due to adrenocortical carcinoma.
    Urology, 1990, Volume: 36, Issue:4

    Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adult; Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Cushing Syndrome; Dihydrotestosterone; Female; Humans; Pregnancy

1990